The present invention relates to a novel form of <i>(S)-1-[N</i>2<i>-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline</i> known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril.
申请公布号
WO03000716(A2)
申请公布日期
2003.01.03
申请号
WO2002GB02850
申请日期
2002.06.19
申请人
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;ROBERTS, RONALD, JOHN;BROWN, JOHN